REFERENCES
- Hyodo H, Furuta H. POCT and system. Rinsho Byori. 2002;50(10):940–946.
- Bissell M. Point-of-care testing at the millennium. Crit Care Nurs Q. 2001;24(1):39–43.
- Warsinke A. Point-of-care testing of proteins. Anal Bioanal Chem. 2009;393(5):1393–1405.
- Armor BL, Britton ML. Diabetes mellitus non-glucose monitoring: Point-of-care testing. Ann Pharmacother. 2004;38(6):1039–1047.
- Matsuyama T. Recent progress in diagnoses of diabetes and its complications. Rinsho Byori. 1995;43(12):1235–1240.
- Weir MR. Microalbuminuria in type 2 diabetics: An important, overlooked cardiovascular risk factor. J Clin Hypertens (Greenwich). 2004;6(3):134–141.
- Luft FC. Microalbuminuria and essential hypertension: Renal and cardiovascular implications. Curr Opin Nephrol Hypertens. 1997;6(6):553–557.
- Koulouridis E. Diabetic nephropathy in children and adolescents and its consequences in adults. J Pediatr Endocrinol Metab. 2001;14(Suppl. 5):1367–1377.
- Shephard MD, Mazzachi BC, Watkinson L, Evaluation of a training program for device operators in the Australian Government’s point of care testing in general practice trial: Issues and implications for rural and remote practices. Rural Remote Health. 2009;9(3):1189.